The Patent Finder

Terms ending in 2036

Array Biopharma Inc.

Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,835,5331-((3S,4R)-4-(3-Fluorophenyl)-1-(2-Methoxyethyl)PYRROLIDIN-3-YL)-3-(4-Methyl-3-(2-Methylpyrimidin-5-YL)-1-Phenyl-1H-PYRAZOL-5-YL)UREA as a Trka Kinase Inhibitor
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,023,570Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 10,138,243Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,174,027Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,174,028Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,799,505Crystalline Form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Hydrogen Sulfate
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 10,208,0242-ARYL- and 2-Heteroaryl-SUBSTITUTED 2-Pyridazin-3(2H)-ONE Compounds as Inhibitors of FGFR Tyrosine Kinases
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 10,766,8812-ARYL- and 2-Heteroaryl-SUBSTITUTED 2-Pyridazin-3(2H)-ONE Compounds as Inhibitors of FGFR Tyrosine Kinases
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,724,102Point Mutations in TRK Inhibitor-Resistant Cancer and Methods Relating to the Same
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited